David F. Wozniak

Prof. Dr. David F. Wozniak

Department of Psychiatry, School of Medicine, Washington University in St. Louis, St. Louis, MO 63110, USA

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 1998 in Neurobiology of Disease
Verified
Journal Article
Closed access
David F. WozniakDavid F. Wozniak
David F. Wozniak
KDK. Dikranian
K. Dikranian
MIM.J. Ishimaru
M.J. Ishimaru
ANA. Nardi
A. Nardi
TCT.D. Corso
T.D. Corso
AFA.S. Fix
A.S. Fix

26 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SMSusan Maloney
Susan Maloney
CYCarla M. Yuede
Carla M. Yuede
CCCatherine E. Creeley
Catherine E. Creeley
SWSasha L. Williams
Sasha L. Williams
JHJacob N. Huffman
Jacob N. Huffman
David F. WozniakDavid F. Wozniak
David F. Wozniak
Epidemiological studies suggest exposures to anesthetic agents and/or sedative drugs (AASDs) in children under three years old, or pregnant women during the third trimester, may adversely affect brain development. Evidence suggests lengthy or repeated AASD exposures are associated with increased risk of neurobehavioral deficits. Animal models have been valuable in determining the type of acute damage in the developing brain induced by AASD exposures, as well as in elucidating long-term functional consequences. Few studies examining very early exposure to AASDs suggest this may be a critical period for inducing long-term functional consequences, but the impact of repeated exposures at these ages has not yet been assessed. To address this, we exposed mouse pups to a prototypical general anesthetic, isoflurane (ISO, 1.5% for 3 hr), at three early postnatal ages (P3, P5 and P7). We quantified the acute neuroapoptotic response to a single versus repeated exposure, and found age- and brain region-specific effects. We also found that repeated early exposures to ISO induced subtle, sex-specific disruptions to activity levels, motor coordination, anxiety-related behavior and social preference. Our findings provide evidence that repeated ISO exposures may induce behavioral disturbances that are subtle in nature following early repeated exposures to a single AASD.

4 August 2015 in Scientific Reports
Verified
Journal Article
Open access
JDJoshua T. Dearborn
Joshua T. Dearborn
SHSteven K. Harmon
Steven K. Harmon
SFStephen C. Fowler
Stephen C. Fowler
KOKaren L. O’malley
Karen L. O’malley
GTGeorge T. Taylor
George T. Taylor
David F. WozniakDavid F. Wozniak
David F. Wozniak
Infantile neuronal ceroid lipofuscinosis (INCL, Infantile Batten disease) is a neurodegenerative lysosomal storage disease caused by a deficiency in palmitoyl protein thioesterase-1 (PPT1). The PPT1-deficient mouse (Cln1−/−) is a useful phenocopy of human INCL. Cln1−/− mice display retinal dysfunction, seizures, motor deficits, and die at ~8 months of age. However, little is known about the cognitive and behavioral functions of Cln1−/− mice during disease progression. In the present study, younger (~1–2 months of age) Cln1−/− mice showed minor deficits in motor/sensorimotor functions while older (~5–6 months of age) Cln1−/− mice exhibited more severe impairments, including decreased locomotor activity, inferior cued water maze performance, decreased running wheel ability, and altered auditory cue conditioning. Unexpectedly, certain cognitive functions such as some learning and memory capabilities seemed intact in older Cln1−/− mice. Younger and older Cln1−/− mice presented with walking initiation defects, gait abnormalities, and slowed movements, which are analogous to some symptoms reported in INCL and parkinsonism. However, there was no evidence of alterations in dopaminergic markers in Cln1−/− mice. Results from this study demonstrate quantifiable changes in behavioral functions during progression of murine INCL and suggest that Parkinson-like motor/sensorimotor deficits in Cln1−/− mice are not mediated by dopamine deficiency.

10 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
David F. WozniakDavid F. Wozniak
David F. Wozniak
KDKelly A. Diggs-Andrews
Kelly A. Diggs-Andrews
SCSara Conyers
Sara Conyers
CYCarla M. Yuede
Carla M. Yuede
JDJoshua T. Dearborn
Joshua T. Dearborn
DGDavid H. Gutmann
David H. Gutmann
Children with neurofibromatosis type 1 (NF1) frequently have cognitive and behavioral deficits. Some of these deficits have been successfully modeled in Nf1 genetically-engineered mice that develop optic gliomas (Nf1 OPG mice). In the current study, we show that abnormal motivational influences affect the behavior of Nf1 OPG mice, particularly with regard to their response to novel environmental stimuli. For example, Nf1 OPG mice made fewer spontaneous alternations in a Y-maze and fewer arm entries relative to WT controls. However, analysis of normalized alternation data demonstrated that these differences were not due to a spatial working memory deficit. Other reported behavioral results (e.g., open-field test, below) suggest that differential responses to novelty and/or other motivational influences may be more important determinants of these kinds of behavior than simple differences in locomotor activity/spontaneous movements. Importantly, normal long-term depression was observed in hippocampal slices from Nf1 OPG mice. Results from elevated plus maze testing showed that differences in exploratory activity between Nf1 OPG and WT control mice may be dependent on the environmental context (e.g., threatening or non-threatening) under which exploration is being measured. Nf1 OPG mice also exhibited decreased exploratory hole poking in a novel holeboard and showed abnormal olfactory preferences, although L-dopa (50 mg/kg) administration resolved the abnormal olfactory preference behaviors. Nf1 OPG mice displayed an attenuated response to a novel open field in terms of decreased ambulatory activity and rearing but only during the first 10 min of the session. Importantly, Nf1 OPG mice demonstrated investigative rearing deficits with regard to a novel hanging object suspended on one side of the field which were not rescued by L-dopa administration. Collectively, our results provide new data important for evaluating therapeutic treatments aimed at ameliorating NF1-associated cognitive/behavioral deficits.

1 November 2019 in Neurobiology of Learning and Memory
Verified
Journal Article
Closed access
SMSusan Maloney
Susan Maloney
CCCatherine E. Creeley
Catherine E. Creeley
RHRichard E. Hartman
Richard E. Hartman
CYCarla M. Yuede
Carla M. Yuede
CZCharles F. Zorumski
Charles F. Zorumski
David F. WozniakDavid F. Wozniak
David F. Wozniak

19 January 2012 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ARAdarsh S. Reddy
Adarsh S. Reddy
David F. WozniakDavid F. Wozniak
David F. Wozniak
NFNuri B. Farber
Nuri B. Farber
JDJoshua T. Dearborn
Joshua T. Dearborn
SFStephen Fowler
Stephen Fowler
MSMark Sands
Mark Sands
Tremor is a prominent phenotype of the twitcher mouse, an authentic genetic model of Globoid-Cell Leukodystrophy (GLD, Krabbe’s disease). In the current study, the tremor was quantified using a force-plate actometer designed to accommodate low-weight mice. The actometer records the force oscillations caused by a mouse’s movements, and the rhythmic structure of the force variations can be revealed. Results showed that twitcher mice had significantly increased power across a broad band of higher frequencies compared to wildtype mice. Bone marrow transplantation (BMT), the only available therapy for GLD, worsened the tremor in the twitcher mice and induced a measureable alteration of movement phenotype in the wildtype mice. These data highlight the damaging effects of conditioning radiation and BMT in the neonatal period. The behavioral methodology used herein provides a quantitative approach for assessing the efficacy of potential therapeutic interventions for Krabbe’s disease.